Legal Representation
Attorney
Thomas G. Peterson
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 8, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 8, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Mar 19, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Mar 19, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Dec 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 22, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 22, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Dec 13, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 8, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 8, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 14, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 8, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Sep 8, 2023 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Sep 8, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Sep 8, 2023 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Sep 8, 2023 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jul 10, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 10, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 8, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 11, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 23, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Dec 23, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 8, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Dec 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 10, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 8, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jun 8, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 8, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 8, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 8, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 8, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 8, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 8, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 8, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 13, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 13, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 23, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 10, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 18, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 18, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 18, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 12, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex
First Use Anywhere:
Dec 1, 2020
First Use in Commerce:
Dec 1, 2020
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"